Ignite Creation Date:
2024-05-06 @ 7:27 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06017310
Status:
RECRUITING
Last Update Posted:
2023-08-30
First Post:
2023-08-24
Brief Title:
Respiferon Project
Sponsor:
Hospices Civils de Lyon
Organization:
Hospices Civils de Lyon
Study Overview
Official Title:
Evaluation of the Type 1 IFN Response in Viral Infections
Status:
RECRUITING
Status Verified Date:
2023-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Respiferon
Brief Summary:
Respiratory viral infections RVIs represent a major public health problem and a great burden in terms of morbidity and mortality in children and adults worldwide To ascertain the source of an infection microbiology laboratories routinely perform a crucial step the search for the pathogen through Polymerase Chain Reaction PCR Due to the extensive variety of pathogens testing for the existence of all potential viruses bacteria or fungi accountable for the infection is an impractical and time-intensive endeavor Furthermore the rise of novel pathogens exemplified by those accountable for the recent SARS-CoV-2 pandemic underscores the urgency of promptly developing new innovative diagnostic tests
To address these needs researchers have dedicated several years to developing indirect methodologies notably centered around utilizing markers derived from the hosts immune system Among these one particularly promising approach focuses on measuring the expression of interferon-stimulated genes which are uniquely triggered by viral infections thereby facilitating viral diagnosis This methodologys efficacy has been proven in the context of SARS-CoV-2 infections
This studys objective is to assess the functionality of such a tool across a spectrum of Respiratory Viral Infections RVIs prevalent within a French population during the winter season
To address these needs researchers have dedicated several years to developing indirect methodologies notably centered around utilizing markers derived from the hosts immune system Among these one particularly promising approach focuses on measuring the expression of interferon-stimulated genes which are uniquely triggered by viral infections thereby facilitating viral diagnosis This methodologys efficacy has been proven in the context of SARS-CoV-2 infections
This studys objective is to assess the functionality of such a tool across a spectrum of Respiratory Viral Infections RVIs prevalent within a French population during the winter season
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None